Literature DB >> 26559124

Antidote for Factor Xa Anticoagulants.

Jean M Connors1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26559124     DOI： 10.1056/NEJMe1513258

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  [Perioperative management of patients on NOACs].

Authors:  C Kelm; K Engels
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-12       Impact factor: 0.840

2.  Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events.

Authors:  Gillian E Caughey; Lisa M Kalisch Ellett; John D Barratt; Sepehr Shakib
Journal:  Ther Adv Drug Saf       Date:  2017-02-10

3.  Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury.

Authors:  Tetsu Akimoto; Tomoyuki Yamazaki; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2016-11-03

Review 4.  New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.

Authors:  Joo Hee Kim; Kyung-Min Lim; Hye Sun Gwak
Journal:  Biomol Ther (Seoul)       Date:  2017-09-01       Impact factor: 4.634

Review 5.  Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.

Authors:  Mark Walsh; Stephanie Fritz; Daniel Hake; Michael Son; Sarah Greve; Manar Jbara; Swetha Chitta; Braxton Fritz; Adam Miller; Mary K Bader; Jonathon McCollester; Sophia Binz; Alyson Liew-Spilger; Scott Thomas; Anton Crepinsek; Faisal Shariff; Victoria Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 6.  Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.

Authors:  Raghavendra Charan P Makam; David C Hoaglin; David D McManus; Victoria Wang; Joel M Gore; Frederick A Spencer; Richeek Pradhan; Hoang Tran; Hong Yu; Robert J Goldberg
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

7.  Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study.

Authors:  Behrad Behdarvand; Emily A Karanges; Lisa Bero
Journal:  BMJ Open       Date:  2019-08-20       Impact factor: 2.692

Review 8.  Implications of apixaban for dental treatments.

Authors:  Adrian Curto; Alberto Albaladejo
Journal:  J Clin Exp Dent       Date:  2016-12-01

Review 9.  Perioperative management of patients on direct oral anticoagulants.

Authors:  Virginie Dubois; Anne-Sophie Dincq; François Mullier; Sarah Lessire; Jonathan Douxfils; Brigitte Ickx; Charles-Marc Samama; Jean-Michel Dogné; Maximilien Gourdin; Bernard Chatelain
Journal:  Thromb J       Date:  2017-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.